# FDA 483 - Lupin Research Inc - February 19, 2020

Source: https://www.globalkeysolutions.net/records/483/lupin-research-inc/144be939-cb1b-47cb-8919-a2d712f21fb7

> FDA 483 for Lupin Research Inc on February 19, 2020. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Lupin Research Inc
- Inspection Date: 2020-02-19
- Product Type: drugs
- Office Name: Division of Clinical Evidence and Analysis 1 (Clinical Policy and Quality)

## Related Documents

- [483 - 2020-02-19](https://www.globalkeysolutions.net/records/483/lupin-research-inc/de85d291-8556-41e0-8dc7-0a682b52a18c)
- [483 - 2020-02-19](https://www.globalkeysolutions.net/records/483/lupin-research-inc/053189dc-f6f8-4bc7-a90d-1c6b2da81fe8)

## Related Officers

- [Dennis Cantellops Paite](https://www.globalkeysolutions.net/people/dennis-cantellops-paite/3336bbb8-8520-4a8a-9085-76e7a55ca773)

Company: https://www.globalkeysolutions.net/companies/lupin-research-inc/0825eb26-1a4a-4b06-ac92-50c121515bab

Office: https://www.globalkeysolutions.net/offices/division-of-clinical-evidence-and-analysis-1-clinical-policy-and-quality/5f95da17-30bb-423f-b892-5ea041823fbd